MENU
IDNA
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

iShares Genomics Immnlgy & Hlthcr ETF (IDNA) Ownership - Who owns iShares Genomics Immnlgy & Hlthcr ETF?

The investment seeks to track the investment results of the NYSE® FactSet® Global Genomics and Immuno Biopharma IndexTM... Show more

Category: #Health

Profile

Category
Health
Address
iShares Trust400 Howard StreetSan Francisco
Phone
1-800-474-2737
Web
www.ishares.com

Details

Group
Domestic Stock Funds
Category
Health
Net Assets
114239950.00
Fund Existence
about 6 years
Turnover
51.00
Capitalization
N/A
Yield
1.25
Total Expense Ratio
0.47
Investment Style
N/A
Risk (Beta)
1.26

Fundamentals

IDNA
Net Assets
114M
Yield
1.25
Fund Existence
about 6 years
Total Expense Ratio
0.47
Turnover
51.00
Investment Style
N/A
Capitalization
N/A
Risk (Beta)
1.26
Manager Tenure
N/A
Administrative Fee
N/A
Annual Report Gross Expense Ratio
0.47
Assets in Top Ten Holdings
58.8M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
114M
Fund Type
ETF
Index Fund
Yes
Management Fee
0.47
Modified Duration
N/A
No Load Fund
Yes
Number of Long Holdings
61.00
Number of Net Holdings
66.00
Number of Short Holdings
5.00
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
43.06%
Gain YTD
1.841
View a ticker or compare two or three
IDNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
iShares Trust400 Howard StreetSan Francisco
Phone
1-800-474-2737
Web
www.ishares.com